Key statistics
As of last trade Oramed Pharmaceuticals Inc (OJU1:STU) traded at 2.69, -16.92% below its 52-week high of 3.23, set on Jan 15, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.71 |
|---|---|
| High | 2.75 |
| Low | 2.64 |
| Bid | 2.65 |
| Offer | 2.71 |
| Previous close | 2.73 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 39.80m |
| Free float | 33.98m |
| P/E (TTM) | 3.15 |
| Market cap | 126.17m USD |
| EPS (TTM) | 1.01 USD |
Data delayed at least 15 minutes, as of Feb 12 2026.
More ▼
Press releases
- Oramed and Lifeward Announce Strategic Transaction
- Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
- Oramed Reports Fiscal Third Quarter 2025 Financial Results
- ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
